Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk

American Journal of Epidemiology
Sarah A AronerMajken K Jensen

Abstract

Apolipoprotein C-III (apoC-III) is a potentially novel biomarker that may play an important role in the pathogenesis of diabetes, particularly when present on the surface of high-density lipoprotein (HDL). In a case-cohort study carried out among 434 incident diabetes cases occurring before 2007 and 3,101 noncases in the Danish Diet, Cancer, and Health Study, we examined associations of baseline (1993-1997) plasma concentrations of apoC-III and subspecies of HDL defined by the presence or absence of apoC-III with risk of diabetes using Cox regression. ApoC-III was strongly associated with risk of diabetes (for top quintile vs. bottom quintile, hazard ratio (HR) = 3.43, 95% confidence interval (CI): 1.75, 6.70; P-trend < 0.001). The cholesterol concentration of HDL (HDL cholesterol (HDL-C)) without apoC-III was inversely associated with risk of diabetes (HR = 0.48, 95% CI: 0.27, 0.85; P-trend = 0.002), more so than total HDL-C (HR = 0.60, 95% CI: 0.35, 1.03; P-trend = 0.04), whereas HDL-C with apoC-III was not associated (HR = 1.05, 95% CI: 0.50, 2.21; P-trend = 0.44) (for HDL-C with apoC-III vs. HDL-C without apoC-III, P-heterogeneity = 0.002). ApoC-III itself is a strong risk marker for diabetes, and its presence on HDL may im...Continue Reading

References

Feb 1, 1985·The Journal of Clinical Investigation·C S WangP Alaupovic
Jan 31, 1972·Biochemical and Biophysical Research Communications·W V Brown, M L Baginsky
Sep 18, 2002·Journal of Lipid Research·Oliviero OlivieriRoberto Corrocher
Oct 18, 2003·Journal of Lipid Research·Oliviero OlivieriRoberto Corrocher
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Lisa Juntti-BerggrenPer-Olof Berggren
Jun 1, 2005·Archives of Medical Research·Henry N GinsbergAntonio Hernandez-Ono
May 30, 2007·Archives of Internal Medicine·Peter W F WilsonRalph B D'Agostino
Aug 21, 2007·The British Journal of Nutrition·José Lopez-MirandaDenis Lairon
Sep 23, 2008·Diabetes Research and Clinical Practice·M ThunanderM Landin-Olsson
Sep 26, 2008·Diabetologia·B CarstensenUNKNOWN Steering Group of the National Diabetes Register
Nov 11, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·A OnatG Can
Nov 12, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Nov 17, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Carlos O MendivilFrank M Sacks
Mar 26, 2010·The New England Journal of Medicine·Kitt Falk PetersenGerald I Shulman
Jan 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Julia KozlitinaHelen H Hobbs
May 11, 2011·Nature Reviews. Endocrinology·Briohny W Smith, Leon A Adams
Jun 15, 2011·Proceedings of the National Academy of Sciences of the United States of America·Rebecka HolmbergLisa Juntti-Berggren
Jul 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hui-Young LeeGerald I Shulman
Aug 11, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A PeterN Stefan
Jan 25, 2012·Nature Reviews. Endocrinology·Brian G DrewBronwyn A Kingwell
Nov 7, 2012·Journal of the American Heart Association·Majken K JensenFrank M Sacks
May 1, 2013·Nature Reviews. Endocrinology·Claudiane Guay, Romano Regazzi
Jun 19, 2014·The New England Journal of Medicine·Jacy CrosbySekar Kathiresan
Jun 19, 2014·The New England Journal of Medicine·Anders Berg JørgensenAnne Tybjærg-Hansen
Oct 16, 2014·World Journal of Diabetes·Neeraj Kumar Agrawal, Saket Kant
Feb 19, 2015·Current Opinion in Endocrinology, Diabetes, and Obesity·Alison B Kohan
Feb 26, 2015·Cell Biochemistry and Biophysics·Ziqi TaoJing Zhao
May 6, 2015·Proceedings of the National Academy of Sciences of the United States of America·Karin ÅvallLisa Juntti-Berggren

❮ Previous
Next ❯

Citations

Dec 12, 2018·Current Opinion in Lipidology·John T Wilkins, Henrique S Seckler
Dec 21, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeremy D FurtadoFrank M Sacks
Dec 18, 2018·Diabetes/metabolism Research and Reviews·Eliza ChristopoulouMoses Elisaf
Jan 2, 2020·Journal of Lipid Research·Manja KochMajken K Jensen
Jul 11, 2020·JAMA Network Open·Manja KochMajken K Jensen
Nov 23, 2019·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Lutgarda BozzettoKirsi H Pietiläinen
Dec 12, 2020·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·David Aguilar-RecarteManuel Vázquez-Carrera
Mar 16, 2021·Frontiers in Immunology·Thomas C MorrisMelissa S Hamilton
Oct 16, 2020·Metabolism: Clinical and Experimental·Laura D'ErasmoMarcello Arca
May 1, 2021·Cells·Blake J CochranKerry-Anne Rye
Apr 12, 2021·The Journal of Clinical Endocrinology and Metabolism·Rain YamamotoFrank M Sacks
Jul 30, 2021·Journal of Lipid Research·John T MelchiorW Sean Davidson
Oct 25, 2021·Journal of Proteomics·Marina RodríguezJosep Ribalta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.